Financial Impact of LungVision™

Increase Diagnostic
Yield and Profitability
Data shows using LungVision™ to overcome CT-to-body divergence, navigate to the nodule, and visually confirm tool-in-lesion during transbronchial lung nodule biopsy can produce diagnostic yields of 90+%. Read how achieving a 94.5% diagnostic yield with LungVision™ enabled the IP team at North Memorial Health Hospital to increase procedure volume by 73% over 2 years and generate a $5,000 contribution margin per procedure.
Comparable Outcomes to RAB
at Fraction of Cost
While there are benefits to the stability, articulation, and smaller catheter diameter of robotics, clinical evidence shows that real-time imaging is the biggest contributor to diagnostic success. Read how Cleveland Clinic demonstrated an 88% diagnostic yield using a manual catheter with LungVision™ for both navigation and real-time imaging at a significant cost savings per case over robot-assisted bronchoscopy (RAB).
Grow Your Program
with AI-Powered Imaging
A high lung nodule diagnostic success rate benefits your patients and can be an engine to grow your lung program and institution. Read how Lung Health Services parlayed their high diagnostic success rate and use of LungVision™ into the ability to draw 65% of their patients from outside the hospital system, grow procedural volume by 92% YOY, and generate ~$8M in incremental downstream revenue.
United States
Body Vision Medical Inc. 133 Boston Post Rd, Suite 100 Weston, MA 02493 US: +1 888-302-5439 International: 603-267-3962
Contact Body Vision Medical
Get in touch with us for information about acquiring LungVision™, the latest product updates, company news and more. A member of our team will be in touch shortly.
First Name
Last Name
Phone Number
Position / Job Title
Organization / Company